These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20635753)

  • 21. Distal embolization during angioplasty for acute myocardial infarction: is pharmacological protection enough?
    De Carlo M; Limbruno U; Pistolesi S; Fontanini G; Petronio AS; Balbarini A; De Caterina R
    Thromb Haemost; 2005 Sep; 94(3):680-1. PubMed ID: 16268491
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
    Mukherjee D; Roffi M
    J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute PCI for ST-segment elevation myocardial infarction: is later better than never?
    Gibbons RJ; Grines CL
    JAMA; 2005 Jun; 293(23):2930-2. PubMed ID: 15956638
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.
    Méndez-Eirín E; Flores-Ríos X; García-López F; Pérez-Pérez AJ; Estévez-Loureiro R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos RA; Vázquez Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):227-33. PubMed ID: 22281285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.
    Kandzari DE; Hasselblad V; Tcheng JE; Stone GW; Califf RM; Kastrati A; Neumann FJ; Brener SJ; Montalescot G; Kong DF; Harrington RA
    Am Heart J; 2004 Mar; 147(3):457-62. PubMed ID: 14999194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current coronary interventional practice.
    Hasdai D
    Cardiologia; 1998 Feb; 43(2):129-33. PubMed ID: 9557368
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?
    Lincoff AM; Topol EJ
    Eur Heart J; 2000 Jun; 21(11):863-7. PubMed ID: 10806004
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
    Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
    N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Counterintuitive contributions to the care of myocardial infarction and the need for randomized trials.
    Morrison DA
    J Am Coll Cardiol; 2003 Sep; 42(6):978-80. PubMed ID: 13678915
    [No Abstract]   [Full Text] [Related]  

  • 30. Abciximab to prevent vessel closure after angioplasty.
    Med Lett Drugs Ther; 1995 Jun; 37(950):52-3. PubMed ID: 7760769
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation.
    Tornvall P; Nilsson T; Lagerqvist B
    J Intern Med; 2006 Oct; 260(4):363-8. PubMed ID: 16961673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
    Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
    Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary percutaneous coronary intervention.
    Kapoor R; Kapoor JR
    N Engl J Med; 2008 Jan; 358(4):431; author reply 432-3. PubMed ID: 18216369
    [No Abstract]   [Full Text] [Related]  

  • 34. Does thrombolytic therapy facilitate or foil primary PCI?
    Leopold JA
    N Engl J Med; 2008 May; 358(21):2277-9. PubMed ID: 18499572
    [No Abstract]   [Full Text] [Related]  

  • 35. PCI at non-PCI centres: immediate or rescue?
    Danchin N; Armstrong PW
    Lancet; 2008 Feb; 371(9612):534-6. PubMed ID: 18280311
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanical reperfusion more than 12 hours after acute myocardial infarction.
    Kanna B; Almadi R
    JAMA; 2005 Oct; 294(16):2031; author reply 2031-2. PubMed ID: 16249414
    [No Abstract]   [Full Text] [Related]  

  • 37. B-type natriuretic peptide assay value small in assessing hypertrophic cardiomyopathy.
    SoRelle R
    Circulation; 2004 Mar; 109(8):e9013-4. PubMed ID: 14993149
    [No Abstract]   [Full Text] [Related]  

  • 38. Facilitation of primary PCI with ReoPro.
    van 't Hof AW; Rasoul S; Ottervanger JP; Dambrink JH
    Eur Heart J; 2005 Aug; 26(15):1563-4; author reply 1564-5. PubMed ID: 15941724
    [No Abstract]   [Full Text] [Related]  

  • 39. [EUROTRANSFER Registry - still a lot to do to optimize treatment of myocardial infarction with elevated ST].
    Gil RJ
    Kardiol Pol; 2010 May; 68(5):544-5. PubMed ID: 20491017
    [No Abstract]   [Full Text] [Related]  

  • 40. Posterior wall myocardial infarction.
    Brown DF; Nadel ES
    J Emerg Med; 2004 Jul; 27(1):75-8. PubMed ID: 15219307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.